| Symbol | Gene Name | Location | ||||||
|
ADRB2
|
adrenergic, beta-2-, receptor, surface
|
5q31-q32 | ||||||
|
AGT
|
angiotensinogen (serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 8)
|
1q41-qter | ||||||
|
AGTR2
|
angiotensin receptor 2
|
Xq22-q23 | ||||||
|
APOA1
|
apolipoprotein A-I
|
11q23-q24 | ||||||
|
APOE
|
apolipoprotein E
|
19q13.2 | ||||||
|
AQP1
|
aquaporin 1 (channel-forming integral protein, 28kD)
|
7p14 | ||||||
|
AQP3
|
aquaporin 3
|
9p13 | ||||||
|
AQP4
|
aquaporin 4
|
18q11.2-q12.1 | ||||||
|
AQP5
|
aquaporin 5
|
12q13 | ||||||
|
BAD
|
BCL2-antagonist of cell death
|
reserved | ||||||
|
BAX
|
BCL2-associated X protein
|
19q13.3-q13.4 | ||||||
|
CASP8
|
caspase 8, apoptosis-related cysteine protease
|
2q33-q34 | ||||||
|
CST3
|
cystatin C (amyloid angiopathy and cerebral hemorrhage)
|
20p11.2 | ||||||
|
DCTN2
|
dynactin 2 (p50)
|
reserved | ||||||
|
EDN1
|
endothelin 1
|
6p23-p24 | ||||||
|
EPO
|
erythropoietin
|
7q21 | ||||||
|
ESR1
|
estrogen receptor 1
|
6q24-q27 | ||||||
|
ESR2
|
estrogen receptor 2 (ER beta)
|
14q21-q22 | ||||||
|
GLA
|
galactosidase, alpha
|
Xq21.3-q22 | ||||||
|
GPRK5
|
G protein-coupled receptor kinase 5
|
10q24-qter | ||||||
|
||||||||